Fundamental Analysis of BIOSIG TECHNOLOGIES INC(NASDAQ:BSGM) stock

Fundamental Rating

BSGM gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. BSGM may be in some trouble as it scores bad on both profitability and health. BSGM is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BSGM has reported negative net income.

BSGM had a negative operating cash flow in the past year.

BSGM had negative earnings in each of the past 5 years.

BSGM had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -1589.24%, BSGM is not doing good in the industry: 98.93% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-1589.24%
ROE	N/A
ROIC	N/A

ROA(3y)-828.31%

ROA(5y)-579.31%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BSGM has a Gross Margin of 66.67%. This is in the better half of the industry: BSGM outperforms 71.66% of its industry peers.

The Profit Margin and Operating Margin are not available for BSGM so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	66.67%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BSGM does not have a ROIC to compare to the WACC, probably because it is not profitable.

BSGM has more shares outstanding than it did 1 year ago.

BSGM has more shares outstanding than it did 5 years ago.

There is no outstanding debt for BSGM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -269.58, we must say that BSGM is in the distress zone and has some risk of bankruptcy.

BSGM's Altman-Z score of -269.58 is on the low side compared to the rest of the industry. BSGM is outperformed by 95.19% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-269.58

ROIC/WACCN/A

WACC9.05%

2.3 Liquidity

BSGM has a Current Ratio of 0.14. This is a bad value and indicates that BSGM is not financially healthy enough and could expect problems in meeting its short term obligations.

BSGM's Current ratio of 0.14 is on the low side compared to the rest of the industry. BSGM is outperformed by 96.26% of its industry peers.

BSGM has a Quick Ratio of 0.14. This is a bad value and indicates that BSGM is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.14, BSGM is doing worse than 96.26% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.14
Quick Ratio	0.14

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 62.99% over the past year.

Looking at the last year, BSGM shows a very negative growth in Revenue. The Revenue has decreased by -93.71% in the last year.

EPS 1Y (TTM)62.99%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%81.25%

Revenue 1Y (TTM)-93.71%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 34.77% on average over the next years. This is a very strong growth

BSGM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 123.61% yearly.

EPS Next Y75.83%

EPS Next 2Y34.77%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-100%

Revenue Next 2Y123.61%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

BSGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year BSGM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

BSGM's earnings are expected to grow with 34.77% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y34.77%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BSGM does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BIOSIG TECHNOLOGIES INC

NASDAQ:BSGM (11/21/2024, 8:16:11 PM)

After market: 1.9 -0.03 (-1.55%)

1.93

+0.06 (+3.21%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap31.42M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1589.24%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	66.67%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.02

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.14
Quick Ratio	0.14
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)62.99%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y75.83%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-93.71%

Revenue growth 3YN/A

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

BIOSIG TECHNOLOGIES INC (BSGM)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens